Indication: 1 This product can be used as an optional drug for the following diseases: (1) Rickettsial diseases, including epidemic typhus, endemic typhus, Rocky Mountain fever, scrub typhus and Q fever. (2) Mycoplasma infections. (3) Chlamydia infections, including psittacosis, venereal diseases, lymphoedema, nonspecific urethritis, salpingitis, cervicitis and trachoma. (4) Relapsing fever. (5) Brucellosis. (6) Cholera. (7) Tularemia. (8) Plague. (9) Chancroid. It should be used in combination with aminoglycosides to treat brucellosis and plague. 2 Since common pathogens are currently resistant to this product,

Indication: 1 This product can be used as an optional drug for the following diseases: (1) Rickettsial diseases, including epidemic typhus, endemic typhus, Rocky Mountain fever, scrub typhus and Q fever. (2) Mycoplasma infections. (3) Chlamydia infections, including psittacosis, venereal diseases, lymphoedema, nonspecific urethritis, salpingitis, cervicitis and trachoma. (4) Relapsing fever. (5) Brucellosis. (6) Cholera. (7) Tularemia. (8) Plague. (9) Chancroid. It should be used in combination with aminoglycosides to treat brucellosis and plague. 2 Since common pathogens are currently resistant to this product,

Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to this class of drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this class of drugs and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. An auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is a second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is a second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.

Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to this class of drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this class of drugs and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. An auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is a second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is a second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.

Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to this class of drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this class of drugs and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. An auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is a second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is a second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.

Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to this class of drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this class of drugs and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. An auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is a second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is a second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.

Indication: Sulfonamides are broad-spectrum antibacterial drugs, but because many common clinical pathogens are resistant to this class of drugs, they are only used for infections caused by sensitive bacteria and other sensitive pathogenic microorganisms. The indications of sulfadiazine (excluding the compound preparations of this class of drugs and trimethoprim) are: 1. Treatment and prevention of epidemic cerebrospinal meningitis caused by sensitive meningococci. 2. Combined with trimethoprim, it can treat otitis media and skin and soft tissue infections caused by Haemophilus influenzae, Streptococcus pneumoniae and other streptococci that are sensitive to it. 3. Astrocyte Nocardia. 4. An auxiliary drug for the treatment of chloroquine-resistant malignant malaria. 5. It is a second-choice drug for the treatment of cervicitis and urethritis caused by Chlamydia trachomatis. 6. It is a second-choice drug for the treatment of neonatal inclusion conjunctivitis caused by Chlamydia trachomatis.

Indication: This product is suitable for the following infections caused by sensitive bacteria: 1. Respiratory tract infections: acute exacerbation of chronic bronchitis, bronchiectasis with infection, acute bronchitis and pneumonia, etc. 2. Urogenital system infections: acute cystitis, acute pyelonephritis, complicated urinary tract infection, acute exacerbation of chronic urinary tract infection, acute and chronic prostatitis, and urethritis or cervicitis caused by Neisseria gonorrhoeae (including those caused by enzyme-producing strains), etc. 3. Gastrointestinal bacterial infections: caused by Shigella, Salmonella, enterotoxigenic Escherichia coli, Aeromonas hydrophila, Vibrio parahaemolyticus, etc. 4. Infections of the abdominal cavity, bile duct, typhoid, etc. 5. Bone and joint infections. 6. Skin and soft tissue infections. 7. Systemic infections such as sepsis. 8. Other infections, such as sinusitis, otitis media, blepharitis, etc.

Indication: This product is suitable for the following infections caused by sensitive bacteria: 1. Respiratory tract infections: acute exacerbation of chronic bronchitis, bronchiectasis with infection, acute bronchitis and pneumonia, etc. 2. Urogenital system infections: acute cystitis, acute pyelonephritis, complicated urinary tract infection, acute exacerbation of chronic urinary tract infection, acute and chronic prostatitis, and urethritis or cervicitis caused by Neisseria gonorrhoeae (including those caused by enzyme-producing strains), etc. 3. Gastrointestinal bacterial infections: caused by Shigella, Salmonella, enterotoxigenic Escherichia coli, Aeromonas hydrophila, Vibrio parahaemolyticus, etc. 4. Infections of the abdominal cavity, bile duct, typhoid, etc. 5. Bone and joint infections. 6. Skin and soft tissue infections. 7. Systemic infections such as sepsis. 8. Other infections, such as sinusitis, otitis media, blepharitis, etc.

Indication: 1. Viral diseases: adult patients with chronic active hepatitis B accompanied by viral replication markers such as HBV-DNA, DNA polymerase positive or HBeAg positive, adult patients with acute and chronic hepatitis C accompanied by positive HCV antibodies and increased alanine aminotransferase (ALT) but without liver function decompensation (Child classification A), genital warts, herpes zoster, pediatric viral pneumonia and upper respiratory tract infection, chronic cervicitis, hepatitis D, etc.; 2. Tumors: hairy cell leukemia, multiple myeloma, non-Hodgkin's lymphoma, chronic leukemia, Kaposi's sarcoma, renal cancer, laryngeal papilloma, melanoma, mycosis fungoides, bladder cancer, basal cell carcinoma, etc.